Immunology and Microbiology
Adalimumab
9%
Agonist
10%
Blood Plasma
22%
C-Reactive Protein
6%
CD163
10%
CD25
5%
CD4
6%
Colitis
7%
Colon
5%
Complement System
6%
Crohn's Disease
100%
Cytokine
17%
Dendritic Cell
16%
Drug Megadose
11%
Glycoprotein
5%
Granulocyte Macrophage Colony-Stimulating Factor
20%
Human Immunodeficiency Virus 1
10%
Immunoregulation
6%
Inflammatory Bowel Disease
27%
Infliximab
59%
Innate Immune System
7%
Interferon Alfa
5%
Interferon Gamma
13%
Interferon Type I
5%
Interleukin 10
13%
Interleukin 17
10%
Interleukin 22
13%
Intestine Flora
10%
Lamina Propria
8%
Lefitolimod
8%
Macrophage
11%
Macrophage Activation
10%
Monospecific Antibody
6%
Normal Human
14%
Oligomerization
10%
Prednisolone
13%
Probiotic
12%
Regulatory T Cell
12%
Secretion (Process)
10%
Supernatant
5%
T Cell
25%
T Cell Culture
7%
T Cell Subset
5%
T-Helper Cell
12%
TLR9
10%
Toll-Like Receptor
10%
Tumor Necrosis Factor
20%
Tumor Necrosis Factor Alpha
11%
Tumor Necrosis Factor Antibody
6%
Ulcerative Colitis
10%
Medicine and Dentistry
Adipose Tissue
5%
Anal Fistula
10%
Bile Acid
7%
Bile Acid Malabsorption
10%
Butyric Acid
5%
C Reactive Protein
6%
Casein
5%
Cholestyramine
5%
Colon
7%
Colon Mucosa
5%
Combination Therapy
5%
Crohn's Disease
11%
Dactylitis
5%
Dermatology
5%
Diarrhea
12%
Disease
8%
Enterocolitis
5%
Enthesitis
5%
Fistula
8%
Gastritis
5%
Gastroenterology
5%
Gut Microbiota
5%
Human Immunodeficiency Virus
7%
Immunomodulation
5%
Infection
5%
Inflammatory Bowel Disease
14%
Inflammatory Disorder
5%
Infliximab
12%
Interferon Type I
5%
Intestinal Epithelium
5%
Lefitolimod
8%
Nivolumab
5%
Panobinostat
5%
Patient with Crohn's Disease
7%
Pharmacokinetics
5%
Premedication
5%
Psoriasis
6%
Retrospective Study
5%
Rheumatology
5%
Selenium 75
5%
Sigmoid
5%
Small Intestine
5%
Spondylitis
5%
Subvalvular Aortic Stenosis
5%
Synovitis
5%
T Cell
12%
T-Helper Cell
6%
Toll Like Receptor 9
5%
Treatment Response
5%
Uveitis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Alcohol Liver Disease
5%
Alpha Interferon
5%
Anus Fistula
5%
Azathioprine
5%
Bile Acid
5%
Calcifediol
5%
Casein
5%
Cell Antigen
5%
Cholecalciferol
5%
Colestyramine
5%
Combination Therapy
5%
Crohn's Disease
42%
Diarrhea
5%
Disease Activity
7%
Etanercept
5%
Fistula
5%
Gamma Interferon
5%
Glycoprotein
5%
Granulocyte Macrophage Colony Stimulating Factor
10%
Inflammation
5%
Inflammatory Bowel Disease
10%
Infliximab
31%
Lipopolysaccharide
5%
Malabsorption
5%
Pharmacokinetics
5%
Placebo
6%
Programmed Death 1 Receptor
5%
Prospective Cohort Study
5%
Retrospective Study
5%
Subvalvular Aortic Stenosis
5%
Tumor Necrosis Factor
7%
Tumor Necrosis Factor Antibody
5%
Ulcerative Colitis
6%
Vaccination Policy
5%
Vitamin D
18%
